Shareholding disclosure

Select Biotechnology Portfolio

Declared position

3.34%

Threshold

Crossed upwards

Timeline

Published

03.08.2018

Transaction

13.07.2018

Voting rights breakdown

Voting rights acquired3.34%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAI8200057

Beneficial owner

Select Biotechnology Portfolio

Declared address

Select Biotechnology Portfolio, Boston, Massachusetts

Listing of ObsEva SA's shares on a Swiss Stock Exchange

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Select Biotechnology Portfolio

ObsEva SA03.08.2018TAI8200057

Disclosure summary

Select Biotechnology Portfolio disclosed a holding in ObsEva SA on the acquisition side, published by SIX Exchange Regulation on 03.08.2018, at 3.34% of voting rights. Notice category: Single shareholder.

Disclosed position

3.34%

Voting rights acquired

Voting rights acquired3.34%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Select Biotechnology Portfolio disclosed a holding in ObsEva SA, published on 03.08.2018.

Publication date03.08.2018

Transaction date13.07.2018

Issuing companyObsEva SA

Beneficial ownerSelect Biotechnology Portfolio

Declared addressSelect Biotechnology Portfolio, Boston, Massachusetts

CategorySingle shareholder

Voting rights acquired3.34%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAI8200057

Conditions

Listing of ObsEva SA's shares on a Swiss Stock Exchange

Source: SIX Exchange Regulation · Publication date: 03.08.2018

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open